Home » Topics » BioWorld Science

BioWorld Science
RSS

Thiazolidinone compounds as antianginal agents from Sankyo

Aug. 23, 1996

Roche reveals EGF-R tyrosine kinase inhibitors

Aug. 23, 1996

Phospholipase A2 inhibitors from SmithKline Beecham

Aug. 23, 1996

European patent protection issued for Hyal's hyaluronan technology

Aug. 23, 1996

Apolipoprotein A-IV as atherosclerosis treatment

Aug. 23, 1996

More endothelin converting enzyme inhibitors from Warner-Lambert

Aug. 23, 1996

Ciba-Geigy claims endothelin converting enzyme inhibitors

Aug. 23, 1996

Roche discloses ETA antagonists for circulatory disorders

Aug. 23, 1996

Endothelin ETA inhibitors described by Roche

Aug. 23, 1996

New calcium entry blocker described by Italian researchers

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.